AJCC melanoma staging update: impact on dermatopathology practice and patient management

被引：39

作者：

Piris, Adriano ^{[1
]}

Mihm, Martin C., Jr. ^{[2
]}

Duncan, Lyn M. ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dermatopathol Unit,Pathol Serv, Boston, MA USA

[2] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

JOURNAL OF CUTANEOUS PATHOLOGY | 2011年 / 38卷 / 05期

关键词：

cancer; dermatopathology; melanoma; AMERICAN JOINT COMMITTEE; SENTINEL LYMPH-NODES; CUTANEOUS MELANOMA; MITOTIC RATE; PROGNOSTIC-SIGNIFICANCE; ULCERATION; BIOPSY;

D O I：

10.1111/j.1600-0560.2011.01699.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Piris A, Mihm MC Jr, Duncan LM. AJCC melanoma staging update: impact on dermatopathology practice and patient management.

引用

页码：394 / 400

页数：7

共 20 条

[1] Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center [J].

Azzola, MF ;

Shaw, HM ;

Thompson, JF ;

Soong, SJ ;

Scolyer, RA ;

Watson, GF ;

Colman, MH ;

Zhang, YT .

CANCER, 2003, 97 (06) :1488-1498

[2] Final Version of 2009 AJCC Melanoma Staging and Classification [J].

Balch, Charles M. ;

Gershenwald, Jeffrey E. ;

Soong, Seng-jaw ;

Thompson, John F. ;

Atkins, Michael B. ;

Byrd, David R. ;

Buzaid, Antonio C. ;

Cochran, Alistair J. ;

Coit, Daniel G. ;

Ding, Shouluan ;

Eggermont, Alexander M. ;

Flaherty, Keith T. ;

Gimotty, Phyllis A. ;

Kirkwood, John M. ;

McMasters, Kelly M. ;

Mihm, Martin C., Jr. ;

Morton, Donald L. ;

Ross, Merrick I. ;

Sober, Arthur J. ;

Sondak, Vernon K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206

[3]

Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO

[4]

2-D

[5]

BALCH CM, 1980, CANCER-AM CANCER SOC, V45, P3012, DOI 10.1002/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO

[6]

2-O

[7] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].

Balch, CM ;

Soong, SJ ;

Gershenwald, JE ;

Thompson, JF ;

Reintgen, DS ;

Cascinelli, N ;

Urist, M ;

McMasters, KM ;

Ross, MI ;

Kirkwood, JM ;

Atkins, MB ;

Thompson, JA ;

Coit, DG ;

Byrd, D ;

Desmond, R ;

Zhang, YT ;

Liu, PY ;

Lyman, GH ;

Morabito, A .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634

[8] Use of Anti-phosphohistone H3 Immunohistochemistry to Determine Mitotic Rate in Thin Melanoma [J].

Casper, David J. ;

Ross, Kate I. ;

Messina, Jane L. ;

Sondak, Vernon K. ;

Bodden, Cheryl N. ;

McCardle, Tim W. ;

Glass, L. Frank .

AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2010, 32 (07) :650-654

[9] Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients [J].

Gershenwald, JE ;

Thompson, W ;

Mansfield, PF ;

Lee, JE ;

Colome, MI ;

Tseng, CH ;

Lee, JJ ;

Balch, CM ;

Reintgen, DS ;

Ross, MI .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :976-983

[10] Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma [J].

Gimotty, PA ;

Van Belle, P ;

Elder, DE ;

Murry, T ;

Montone, KT ;

Xu, XW ;

Hotz, S ;

Raines, S ;

Ming, ME ;

Wahl, P ;

Guerry, D .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8048-8056

← 1 2 →